Startside539523 • BOM
add
Alkem Laboratories Ltd
Forrige sluttkurs
4 723,95 ₹
Dagsintervall
4 609,50 ₹ - 4 752,90 ₹
Årsintervall
4 409,90 ₹ - 6 440,00 ₹
Markedsverdi
553,45 mrd. INR
Gjennomsnittlig volum
3,59k
P/E-tall
25,73
Utbytte
0,91 %
Hovedbørs
NSE
I nyhetene
Økonomi
Resultatregnskap
Omsetning
Nettoomsetning
(INR) | des. 2024info | Endring år til år |
---|---|---|
Omsetning | 33,74 mrd. | 1,52 % |
Driftskostnader | 14,96 mrd. | 8,29 % |
Nettoomsetning | 6,26 mrd. | 5,19 % |
Netto resultatmargin | 18,55 | 3,63 % |
Fortjeneste per aksje | 52,34 | −2,59 % |
EBITDA | 7,39 mrd. | 4,74 % |
Faktisk avgiftssats | 12,35 % | — |
Balanseregnskap
Totale aktiva
Totale passiva
(INR) | des. 2024info | Endring år til år |
---|---|---|
Kontant / kortsiktige inv. | 22,89 mrd. | −36,59 % |
Totale aktiva | — | — |
Totale passiva | — | — |
Total egenkapital | 119,10 mrd. | — |
Utestående aksjer | 119,57 mill. | — |
P/B-forhold | 4,91 | — |
Avkastning på aktiva | — | — |
Avkastning på kapital | 12,59 % | — |
Kontantstrøm
Netto kontantstrøm
(INR) | des. 2024info | Endring år til år |
---|---|---|
Nettoomsetning | 6,26 mrd. | 5,19 % |
Kontantstrøm fra drift | — | — |
Kontanter fra investering | — | — |
Kontanter fra finansiering | — | — |
Netto kontantstrøm | — | — |
Fri kontantstrøm | — | — |
Om
Alkem Laboratories Limited is a leading Indian multinational pharmaceutical company headquartered in Mumbai, India. Specialising in generics and speciality pharmaceuticals, Alkem manufactures and markets a diverse portfolio of pharmaceutical generics, formulations and nutraceuticals across India and global markets.
With over five decades of expertise in the pharmaceutical industry, Alkem's journey began with a vision to transform India's healthcare landscape. Today, the company has established its presence in over 40 countries, operating 19 state-of-the-art manufacturing facilities and driving innovation through a team of 500+ scientists. Backed by a robust portfolio of 800+ brands, Alkem continues to set industry benchmarks in research, development, and manufacturing excellence.
Alkem primarily focuses on developing medications for a wide range of therapeutic areas, including infectious diseases, gastrointestinal disorders, pain management, gynecological conditions, pediatrics, osteoporosis, arthritis, cardiovascular diseases, diabetes, and several other critical health concerns. Wikipedia
Grunnlagt
1973
Hovedkvarter
Nettsted
Ansatte
17 432